Dow AgroSciences LLC, which seems to sign a new deal every week, announced two, in fact, in the past eight days. The Indianapolis-based developer of agricultural products announced Nov. 24 that its Canada subsidiary acquired the assets of Hyland Seeds, a division of Thompsons Ltd. of Blenheim, Ontario. Dow Agro is adding distribution capacity for the 2010 launch of its SmartStax variety of genetically modified seeds. Then on Dec. 1, Dow Agro invested an undisclosed amount in Ontario-based Agrisoma Biosciences Inc. The companies have been collaborating since 2004 to genetically engineer plant traits, and now will expand their work into field crops, such as corn and soybeans. Dow Agro’s investment secured it a commercial license option for Agrisoma technology.
The Indiana Clinical and Translational Sciences Institute has received $2.5 million to help it turn laboratory discoveries into treatments faster. The money will be used to bring the University of Notre Dame into the institute, now a partnership of Indiana and Purdue universities. Other funds will go to build up the institute’s Web site and to figure out best practices for community-health efforts. Nearly $1 million of the funds will be used to recruit patients to participate in clinical trials conducted by physicians at the Indiana Clinic, a new joint venture of the IU School of Medicine and the Indianapolis-based Clarian Health hospital system.
Officials of Wishard Health Services released details Tuesday of their first request for bids on construction of a new Wishard hospital downtown. Hospital officials are looking for contractors to build a 2,300-space parking garage, the first of five buildings to house the new hospital. Marion County voters agreed Nov. 3 to back bonds that Wishard’s parent organization will sell to fund the $754 million project. A meeting about the bid process will be held Dec. 17. The new hospital is scheduled to open in December 2013.